Literature DB >> 16923867

Should metformin be prescribed to overweight adolescents in whom dietary/behavioural modifications have not helped?

E Webb1, R Viner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923867      PMCID: PMC2082931          DOI: 10.1136/adc.2006.098962

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  16 in total

1.  Longitudinal study on pubertal insulin resistance.

Authors:  M I Goran; B A Gower
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

2.  Treatment with metformin of non-diabetic men with hypertension, hypertriglyceridaemia and central fat distribution: the BIGPRO 1.2 trial.

Authors:  M A Charles; E Eschwège; P Grandmottet; F Isnard; J M Cohen; J L Bensoussan; H Berche; O Chapiro; P André; P Vague; I Juhan-Vague; J M Bard; M Safar
Journal:  Diabetes Metab Res Rev       Date:  2000 Jan-Feb       Impact factor: 4.876

3.  Metformin and reduced risk of cancer in diabetic patients.

Authors:  Josie M M Evans; Louise A Donnelly; Alistair M Emslie-Smith; Dario R Alessi; Andrew D Morris
Journal:  BMJ       Date:  2005-04-22

4.  Beneficial effects of metformin in normoglycemic morbidly obese adolescents.

Authors:  J P Kay; R Alemzadeh; G Langley; L D'Angelo; P Smith; S Holshouser
Journal:  Metabolism       Date:  2001-12       Impact factor: 8.694

Review 5.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

6.  The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.

Authors:  M Freemark; D Bursey
Journal:  Pediatrics       Date:  2001-04       Impact factor: 7.124

7.  Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study.

Authors:  L S Webber; S R Srinivasan; W A Wattigney; G S Berenson
Journal:  Am J Epidemiol       Date:  1991-05-01       Impact factor: 4.897

8.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

9.  Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.

Authors:  K H Chou; H von Eye Corleta; E Capp; P M Spritzer
Journal:  Horm Metab Res       Date:  2003-02       Impact factor: 2.936

Review 10.  Metformin: new understandings, new uses.

Authors:  Ripudaman S Hundal; Silvio E Inzucchi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more
  3 in total

1.  A randomized, triple masked, placebo-controlled clinical trial for controlling childhood obesity.

Authors:  Hasan Rezvanian; Mahin Hashemipour; Roya Kelishadi; Naser Tavakoli; Parinaz Poursafa
Journal:  World J Pediatr       Date:  2010-11-16       Impact factor: 2.764

2.  Larrad biliopancreatic diversion in Sprague-Dawley rats. Analysis of weight loss related to food intake.

Authors:  Hugo Mendieta-Zerón; Alvaro Larrad-Jiménez; Gema Frühbeck; Katia Da Boit; C Diéguez
Journal:  Obes Surg       Date:  2008-10-15       Impact factor: 4.129

3.  WITHDRAWN: Interventions for treating obesity in children.

Authors:  Hiltje Oude Luttikhuis; Louise Baur; Hanneke Jansen; Vanessa A Shrewsbury; Claire O'Malley; Ronald P Stolk; Carolyn D Summerbell
Journal:  Cochrane Database Syst Rev       Date:  2019-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.